Search result for "eylea"

Approximately 9 trademarks found.

EYLEA

pharmaceutical preparations, namely, ophthalmic; pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: REGISTERED AND RENEWED

Filed on: 2008-06-30

EYLEA

Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: REGISTERED AND RENEWED

Filed on: 2011-01-04

EYLEA

Syringes for medical purposes and for injections; injection device for pharmaceuticals; injection needles

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: THIRD EXTENSION - GRANTED

Filed on: 2021-05-10

EYLEA

Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: REGISTERED

Filed on: 2017-12-15

EYLEA4U

Providing medical information; Providing information to patients in the field of administering medication; Individual medical counseling services...

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

Filed on: 2023-05-12

EYLEA4U

providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for...

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: REGISTERED AND RENEWED

Filed on: 2011-05-23

EYLEA HD

Pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: STATEMENT OF USE - TO EXAMINER

Filed on: 2022-02-11

EYLEA PATIENT COMPANION

Downloadable software application for providing medical information to patients and managing medical treatment data for patients

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: FIRST EXTENSION - GRANTED

Filed on: 2021-12-21

EYLEA (AFLIBERCEPT) INJECTION 4U

providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for...

Current Owner: Regeneron Pharmaceuticals, Inc.

Status: SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Filed on: 2013-06-10